Keryx Biopharmaceuticals Appoints Scott A. Holmes as Chief Financial Officer
July 27, 2015 08:00 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, July 27, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the appointment of Scott A. Holmes to Chief Financial Officer effective immediately. Mr. Holmes...
Keryx Receives CHMP Positive Opinion for Fexeric(R) (Ferric Citrate Coordination Complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease
July 24, 2015 07:10 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, July 24, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
Keryx Announces Two National Insurance Providers Added Auryxia(TM) to Their Medicare Part D Formularies
June 24, 2015 08:00 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, June 24, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for people with renal disease,...
Keryx Biopharmaceuticals to Present at the JMP Securities Life Sciences Conference 2015
June 16, 2015 09:00 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, June 16, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc., (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease,...
CORRECTING and REPLACING -- Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference
May 12, 2015 18:32 ET
|
Keryx Biopharmaceuticals, Inc.
NEW YORK, May 12, 2015 (GLOBE NEWSWIRE) -- In the press release issued on May 5, 2015 by Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) under the same headline, please note that the May 13th...
Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference
May 05, 2015 16:30 ET
|
Keryx Biopharmaceuticals, Inc.
NEW YORK, May 5, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that Greg Madison, the Company's Chief Executive Officer, will be presenting a company overview,...
Keryx Biopharmaceuticals Announces First Quarter 2015 Financial Results
May 04, 2015 07:15 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON and NEW YORK, May 4, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with...
Keryx Biopharmaceuticals Completes Transition of CEO Role to Greg Madison
April 30, 2015 16:30 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON, April 30, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease...
Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2015 Financial Results
April 27, 2015 16:30 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON and NEW YORK, April 27, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with...
Keryx Biopharmaceuticals Appoints John F. Neylan, MD, as Chief Medical Officer
April 23, 2015 08:00 ET
|
Keryx Biopharmaceuticals, Inc.
BOSTON and NEW YORK, April 23, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company"), today announced the appointment of John F. Neylan, MD to the newly created...